Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma

Published:2019-01 Issue:1 Volume:48 Page:43-48
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Leppänen Joni,Lindholm Ville,Isohookana Joel,Haapasaari Kirsi-Maria,Karihtala Peeter,Lehenkari Petri P.,Saarnio Juha,Kauppila Joonas H.,Karttunen Tuomo J.,Helminen Olli,Huhta Heikki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference41 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Int J Cancer,2015

2. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;JAMA Oncol,2017

3. The influence of protein:Energy value of the ration and level of feed intake on the energy and nitrogen metabolism of the growing pig. 1. Energy metabolism;Br J Nutr,1983

4. Impact of the physical microenvironment on tumor progression and metastasis;Curr Opin Biotechnol,2016

5. Pancreatic cancer and its stroma: a conspiracy theory;World J Gastroenterol,2014

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models;Pharmaceutical Research;2024-08-28

2. Contemporary Approaches to Immunotherapy of Solid Tumors;Cancers;2024-06-19

3. PROGNOSTIC VALUE OF THE DENSITY OF TUMOR-INFILTRATING LYMPHOCYTES AND ITS ASSOCIATION WITH CLINICAL-MORPHOLOGICAL FEATURES OF COLON ADENOCARCINOMAS;Experimental Oncology;2024-05-31

4. Automatic quantification of tumor-stroma ratio as a prognostic marker for pancreatic cancer;PLOS ONE;2024-05-21

5. Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges;Cancers;2024-02-15